Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Understanding the timing of transmission dynamics of Covid-19 is crucial for optimising public health interventions and reducing the burden on communities.

Man wearing a face mask on public transport

Knowledge of the period of high infectiousness is particularly useful in the context of contact tracing as it allows to identify the contacts at highest risk of having contracted the disease, maximising the number of infectious individuals in quarantine while minimising the number of people unnecessarily isolated. The preprint paper 'The timing of Covid-19 transmission', published in MedRxiv, is centered around the question “When is someone who has been infected with COVID-19 most likely to infect others?”.

The analysis focuses on individuals who eventually develop symptoms, studying 191 transmission pairs from multiple data sets. Each transmission pair includes an index case and a secondary case, infected by the index case. Datasets were selected because they contained information not only about the dates of onset of symptoms for both cases, but also intervals of exposure for the index and/or secondary case. For these pairs and individuals, four key timings related to Covid-19 transmission were known or inferred.

Read more about the key findings in a blog on the Coronavirus Fraser Group website. There is also in a media update on the Big Data Institute website

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.